Shares of HIVE Blockchain Technologies Ltd. (CVE:HIV – Get Free Report) have been given an average rating of “Strong Buy” by the five brokerages that are covering the firm, Marketbeat.com reports. Five research analysts have rated the stock with a strong buy recommendation.
A number of brokerages have recently issued reports on HIV. Rosenblatt Securities upgraded HIVE Blockchain Technologies to a “strong-buy” rating in a research note on Friday, March 7th. Keefe, Bruyette & Woods upgraded shares of HIVE Blockchain Technologies to a “moderate buy” rating in a research note on Wednesday, January 8th. Finally, Roth Capital raised shares of HIVE Blockchain Technologies to a “strong-buy” rating in a research report on Wednesday, December 18th.
Get Our Latest Analysis on HIVE Blockchain Technologies
HIVE Blockchain Technologies Price Performance
HIVE Blockchain Technologies Ltd. is a business services company in the Business Services industry.
See Also
- Five stocks we like better than HIVE Blockchain Technologies
- How to Use the MarketBeat Excel Dividend Calculator
- Quantum Computing: The $6.5 Billion Opportunity You Can’t Ignore
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Are Tariffs Threatening Disney’s Comeback Story?
- What is the FTSE 100 index?
- Is Alphabet a Generational Buying Opportunity at These Levels?
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
